TrialThe journal of headache and pain2022

Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study.

Roger Cady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.